News
Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall
14 Mar 24
Analyst Color, Biotech, News, Health Care, Price Target, Analyst Ratings, Movers, Trading Ideas, General
Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Views
14 Mar 24
News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
14 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Thursday's Intraday Session
14 Mar 24
Movers
Crude Oil Moves Higher; Dollar General Posts Upbeat Earnings
14 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
RBC Capital Downgrades Spruce Biosciences to Sector Perform, Lowers Price Target to $2
14 Mar 24
News, Downgrades, Price Target, Analyst Ratings
US Stocks Higher; Producer Prices Rise 0.6% In February
14 Mar 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Global, Intraday Update, Markets, Trading Ideas
HC Wainwright & Co. Downgrades Spruce Biosciences to Neutral
14 Mar 24
News, Downgrades, Analyst Ratings
Why Is Rare Endocrine Disorder-Focused Spruce Biosciences Stock Plummeting On Thursday?
14 Mar 24
Biotech, Earnings, News, Guidance, Health Care, Movers, General
12 Health Care Stocks Moving In Thursday's Pre-Market Session
14 Mar 24
Movers
Leerink Partners Downgrades Spruce Biosciences to Market Perform, Lowers Price Target to $2
14 Mar 24
News, Downgrades, Price Target, Analyst Ratings
JMP Securities Maintains Market Outperform on Spruce Biosciences, Lowers Price Target to $3
14 Mar 24
News, Price Target, Analyst Ratings
Guggenheim Downgrades Spruce Biosciences to Neutral
14 Mar 24
News, Downgrades, Analyst Ratings
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
14 Mar 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Wednesday's After-Market Session
13 Mar 24
Movers
Spruce Biosciences Reports FY23 EPS $(1.24) Vs $(1.96) YoY; Collaboration Revenue For The Year Ended December 31, 2023 Was $10.089M
13 Mar 24
Earnings, News
RBC Capital Reiterates Outperform on Spruce Biosciences, Maintains $9 Price Target
5 Mar 24
News, Price Target, Reiteration, Analyst Ratings
RBC Capital Maintains Outperform on Spruce Biosciences, Raises Price Target to $9
26 Feb 24
News, Price Target, Analyst Ratings
Guggenheim Initiates Coverage On Spruce Biosciences with Buy Rating, Announces Price Target of $10
21 Feb 24
News, Price Target, Initiation, Analyst Ratings
12 Health Care Stocks Moving In Tuesday's After-Market Session
30 Jan 24
Movers
Press releases
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
22 Apr 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB
8 Apr 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB
4 Apr 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB
31 Mar 24
News, Legal, Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB
27 Mar 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB
23 Mar 24
News, Legal, Press Releases
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
21 Mar 24
Press Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB
15 Mar 24
Press Releases
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
14 Mar 24
Press Releases
Thinking about buying stock in BigBear.ai, MicroCloud Hologram, TRACON Pharmaceuticals, Spruce Biosciences, or Recursion Pharmaceuticals?
14 Mar 24
Opinion, Press Releases
Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH
13 Mar 24
Press Releases
Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
30 Jan 24
Press Releases